Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001989533-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | 2025-12-09 | JAZZ | Henderson Mary Elizabeth | SVP, Technical Ops | S - Sale | $169.51 | -2,238 | 19.5K | -10% | -$379.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-12-09 | S | D | 2,238 | $169.51 | 19,508 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $169.00 to $169.82. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |